ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO829

Readmission After Gastrointestinal Bleeding Hospitalization Type in Dialysis Patients

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1500 Health Maintenance, Nutrition, and Metabolism

Authors

  • Jiao, Yue, Fresenius Medical Care, Waltham, Massachusetts, United States
  • Alejos, Belen, Fresenius Medical Care, Bad Homburg, Germany
  • Wolf, Melanie, Fresenius Medical Care, Bad Homburg, Germany
  • Larkin, John W., Fresenius Medical Care, Waltham, Massachusetts, United States
  • Winter, Anke, Fresenius Medical Care, Bad Homburg, Germany
  • Chaudhuri, Sheetal, Fresenius Medical Care, Waltham, Massachusetts, United States
  • Stauss-Grabo, Manuela, Fresenius Medical Care, Bad Homburg, Germany
  • Usvyat, Len A., Fresenius Medical Care, Waltham, Massachusetts, United States
  • Hymes, Jeffrey L., Fresenius Medical Care, Waltham, Massachusetts, United States
  • Maddux, Franklin W., Fresenius Medical Care AG & Co KGaA, Bad Homburg, Hessen, Germany
  • Wheeler, David C., University College London, London, United Kingdom
  • Stenvinkel, Peter, Dept of Renal Medicine Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
  • Floege, Jürgen, University Hospital RWTH Aachen, Division of Nephrology and Clinical Immunology, Aachen, Germany

Group or Team Name

  • On Behalf of the INSPIRE Core Group.
Background

The incidence of gastrointestinal bleeding (GIB) is high in the dialysis population. GIB episodes frequently lead to hospitalization, yet associated outcomes have not been defined and may differ by GIB type. The INSPIRE group aimed to define the all-cause hospital readmission rates after an index GIB hospitalization considering the type of GIB (upper or lower).

Methods

We used data on adult chronic dialysis patients who were hospitalized for a GIB in the United States during Jan-2018 to Mar-2021. GIB hospitalizations were identified from ICD discharge diagnosis codes (Zhao et al., AHRQ 2006). All-cause readmission rate considered events within 30 days from an index GIB hospitalization by GIB type. Index GIB hospitalizations with an unspecified location for the GIB were not included in the analysis of GIB types.

Results

In a population of 405,530 patients, 19,663 GIB hospitalizations occurred. Overall, there was a 26.4% all-cause 30-day readmission rate after an index GIB hospitalization. Readmission rate was consistent by GIB types at 26.4% for upper and 26.0% for lower GIB hospitalizations. Readmission rates after a GIB hospitalization were highest among patients 18-44 years old for all GI bleed types (Figure 1). Readmission rates after an upper GIB were higher for females, patients ≥75 years old, and those with a black and other race. Readmission after a lower GIB was most common among patients with an Asian and unknown race.

Conclusion

All-cause readmission rate after a GIB hospitalization was about 26% for all GIB types. Readmission rates were higher (>30%) among younger patients for upper and lower GIBs. Sex-dependent differences in readmission rates were observed after an upper-GIB hospitalization, as well as differences by age and race in readmission rates after an upper- and lower-GIB hospitalization. Further adjusted analyses are needed to confirm these findings and understand the disparities in outcomes.

Funding

  • Commercial Support – Fresenius Medical Care